We explored mechanisms involved in B cell self-tolerance against brain autoantigens in a double-transgenic mouse model carrying the Ig H-chain (introduced by gene replacement) and/or the L-chain (conventional transgenic) of the mAb 8.18C5, specific for the myelin oligodendrocyte glycoprotein (MOG 
M yelin oligodendrocyte glycoprotein (MOG)
2 is a brain autoantigen with intriguing properties. First, increasing evidence suggests that MOG-specific T and B cells play a crucial role in inflammatory demyelinating disease of the CNS in both experimental and clinical situations (1) (2) (3) (4) . Second, MOG has several properties setting it apart from other myelin proteins. It is exclusively localized on the outer surface of the myelin sheath, where it can be readily attacked by specific Ab mediating demyelination (5, 6) . In addition, the expression of MOG is restricted to the CNS, and it appears late during development of myelin (7) (8) (9) (10) (11) .
Several mechanisms of B cell tolerance have been identified in Ig-transgenic animal models (12) (13) (14) (15) (16) (17) . Clonal deletion and receptor editing occur at distinct developmental stages during B cell development in the bone marrow (18) . On contact with self-Ag, immature B cells are preferentially induced to undergo receptor editing, i.e., secondary rearrangements of the Ig genes to alter their selfreactive specificity (16, 17) . Cells that fail to edit their autoreactive Ag receptors are prone to apoptotic deletion even before entering the mature B cell pool.
Would any of these mechanisms act during the development of MOG-specific B cells? Alternatively, considering that recirculating MOG-specific Abs remain innocuous as long as the tight endothelial blood-brain barrier prevents them from reaching their target structure on the myelin surface, would MOG-autoreactive B cells be generated in bone marrow and spleen without any selftolerogenic control?
We have recently generated an Ig H-chain "knock-in" transgenic mouse (denominated TH) to retrace the function and fate of MOG-reactive B cells in vivo (4) . The Ig H-chain V region was derived from the MOG-specific mAb 8.18C5, an Ab, which induces strong demyelination and clinical exacerbation in experimental autoimmune encephalomyelitis experiments (1, 6) . The TH mice showed a diverse B cell repertoire with about one-third of the B cells binding MOG. Thus, in this transgenic setup, the MOGspecific B lymphocytes were not tolerized and secreted MOGbinding Ab, which, on opening the endothelial blood-brain barrier, caused substantial myelin destruction. The absence of B cell tolerance in this case is possibly due to clonal ignorance, because under normal circumstances MOG is secluded behind the bloodbrain barrier and does not interact with peripheral immune cells.
In this study, we show that transgenic B cells expressing both the Ig H-and Ig L-chain of the 8.18C5 mAb are eliminated from the mature B cell repertoire. In Ig H ϩ L-chain-transgenic mice, the transgenic mog L-chain is silenced by editing in immature B cells of the B220 low IgM low IgD Ϫ phenotype. In addition, we show that elimination of this particular specificity is not mediated by MOG itself but rather by another cross-reacting self-Ag(s).
Materials and Methods

Transgenic mice
The variable region of the L-chain gene was cloned from the MOG-specific hybridoma clone 8.18C5 (7) and inserted in an expression vector including the C region, the intron enhancer, and the 3Ј-enhancer. A 1.7-kb SacI fragment of genomic DNA containing the rearranged V mog gene was subcloned from a larger clone isolated from a genomic phage library of the hybridoma 8.18C5. This DNA fragment including 1 kb 5Ј-regulatory and untranslated sequences, the two exons encoding the leader sequence, and the entire VJ rearranged gene and the intron between them was then inserted 5Ј of the C intron sequence in transcriptional orientation, followed by a 1.1-kb DNA fragment containing the 3Ј-enhancer. The entire sequence of the V mog gene, including coding exons and the intron between leader sequences and V, as well as 125 bp of the region 5Ј of the AUG codon including promoter sequences was determined. The obtained sequence correspond to an unmutated germline V8 gene joined to J5. On comparison with known Ig genes, the V mog gene was found to be identical with the chain gene of the phosphorylcholine-specific hybridoma 253.15D10 (19) , except for a single silent point mutation at aa 110 (CTG/ Leu3 TTG/Leu) in the J5 region of our V mog gene. This point mutation served for unequivocal identification of the transgenic sequence, where the expression of genes was studied in immune organs.
For generation of transgenic mice, a 8.5-kb EcoRI fragment of genomic DNA was separated from vector sequences and injected into fertilized oocytes of (C57BL/6 ϫ CBA) F 1 mice. Three lines of mog -transgenic mice were obtained, bearing ϳ2, 8, and 20 copies of the transgene. The two -transgenic lines with the higher copy numbers of the transgene were crossed back into C57BL/6 and with the TH knock-in mice. The TH knock in mice have been described (4). RAG-2-deficient mice were kindly provided by Dr. H. Mossmann (Max-Planck-Institut für Immunbiologie, Freiburg, Germany). The generation and phenotype of MOG knockout mice will be described elsewhere (D. Pham-Dinh, P. Daubas, C. Vizler, C. Delarasse, D. Dimitri, J. Bauer, A. Dierich, M. LeMeur, G. Roussel, J.-L. Nassbaum, R. Liblau, and A. Dautigny, manuscript in preparation).
Flow cytometric analysis
Single-cell suspensions were prepared from spleen and bone marrow of adult (6-to 8-wk-old) mice or from spleen and liver of first day newborn mice. RBC were lysed by incubation in 0.165 M NH 4 Cl for 10 min. Cells were washed with PBS/1% FCS and stained with the following Ab conjugates: anti-IgM a -FITC (clone DS-1; PharMingen, San Diego, CA); antiIgM b -FITC (clone AF6-78, PharMingen); goat anti-mouse IgM-biotin (Southern Biotechnology Associates, Birmingham, AL); anti-B220-FITC (PharMingen); anti-IgD-FITC (PharMingen); and biotin-labeled recombinant MOG. The biotinylated mAb 493 (20) was supplied by Ton Rolink (Basel Institute for Immunology, Basel, Switzerland). The rabbit anti-8.18C5-idiotypic Ab has been described (21) and was used in combination with Cy3-labeled goat anti-rabbit-IgG Ab (Jackson ImmunoResearch, West Grove, PA). Biotin conjugates were developed with streptavidin-PE (PharMingen), and dead cells were excluded by labeling with propidium iodide. Samples were analyzed by a FACScan (Becton Dickinson) and evaluated with the Lysis II program.
Cell sorting and RT-PCR
This experiment was performed as follows. First, individual newborn livers from appropriate crosses were analyzed in FACS for the presence of the diagnostic IgM ϩ MOG ϩ "diagonal" population, as indicative of expression of both transgenic TH and mog chains (see Fig. 2 ). The organs diagnosed as being TH mog or TH transgenic were pooled, and MOG-binding and MOG-nonbinding cells were separated using biotinylated recombinant MOG and streptavidin-coated magnetic beads. Additionally, tissue biopsies of the pups were analyzed individually by PCR for the presence of the mog transgene. We found in all cases correlation between the appearance of the diagonal IgM ϩ MOG ϩ fraction and the presence of both TH and mog transgenes. Single-cell suspensions from pooled TH-and TH mog neonatal livers were incubated with biotin-conjugated (recombinant) rMOG (at a dilution of 1:500) for 30 min at 4°C. After a washing, streptavidin-coupled magnetic beads were added to the cells to separate MOG-binding and -nonbinding cells via MACS columns (Miltenyi Biotec, Bergisch Gladbach, Germany). RNA was extracted from the sorted cells, and 2 g were used for cDNA synthesis as described (4) . PCR amplification was performed with the primer pairs RAG-1S and RAG-1AS and RAG-2S and RAG-2AS (22) for detection of RAG-1 and RAG-2 expression, respectively. As control for the quality of the cDNA preparation, we used ␤-actin-specific primers:
For primer 1 (5Ј-TGCTAGGAGCCAGGGCAGTAATC-3Ј) and primer 2 (5Ј-TACAATGAGCTGCGTGTGGCC-3Ј), RNA extracted from mouse bone marrow was used as positive control for the amplification of RAG-1 and RAG-2. In all cases, the conditions for PCR amplification were 30 cycles at 1 min at 94°C, 1 min at 60°C, and 1 min at 72°C for each cycle. PCR products were identified on ethidium bromide-stained agarose gels. Primers 5V (5Ј-CAGATCTGCCTGGTACCAGCAGAAACC-3Ј) and MC5 (5Ј-CGGGATCCACTGGATGGTGGGAAGATGG-3Ј) were used for amplification of Ig -chain sequences which were subsequently cloned into the vector pCR2.1 (Invitrogen, Groningen, The Netherlands). Individual clones were analyzed by Southern blot hybridization using digoxinlabeled primers. First, the identity of the clones was determined with an internal C primer (5C: 5Ј-GCTGATGCTGCACCAACTGT-3Ј), and then transgenic mog sequences were identified with a V-J junctional primer (C5VJi: 5Ј-GGACGTGAGCGGATAACTATG-3Ј) specific for the mog transgene. Finally, the sequence of selected transgenic and nontransgenic clones was established by TopLab (Martinsried, Germany).
Western blot analysis
Protein extracts of mouse brain and rMOG were run on a 12.5% polyacrylamide gel and blotted onto a nitrocellulose membrane (Hybond ECL, Amersham International, Arlington Heights, IL). The blot was probed with biotinylated 8.18C5 mAb (1:1000) or anti-actin mouse mAb (1:1000, Amersham) and detected with streptavidin-peroxidase (PharMingen) and peroxidase-conjugated goat anti-mouse Ig (Jackson ImmunoResearch), respectively. The signals were developed with the ECL system according to the instruction of the manufacturer (Amersham).
Results
Generation of TH mog -transgenic mice
We generated Ig-transgenic mice the B cells of which share their specificity with the MOG reactive mAb 8.18C5, an Ig with a highly demyelinating potential (23). We cloned the Ig H-and Lchain genes from the 8.18C5 hybridoma, and the rearranged V H region was used for the generation of the V H knock-in (TH) mice, as described previously (4). Genomic DNA including the rearranged V mog gene as well as intron and C 3Ј-enhancer was injected into oocytes to produce conventional IgL-transgenic mice (designated mog ). Both TH knock-in and mog -transgenic mice were crossed into the C57BL/6 strain. To generate double-transgenic animals (TH mog ), TH and mog -transgenic mice of the fourth backcross into C57BL/6 were bred. The functional expression of the transgenic mog gene was demonstrated both by the presence of V mog in-frame transcripts in the spleens of transgenic mice and by the association with the transgenic Ig H-chain on the surface of immature B cells (see below).
B cell phenotype of adult TH mog mice
In mog single-transgenic mice, the mog L-chain does not contribute to MOG specificity. There are neither MOG-specific B cells nor Abs detectable in these animals (not shown). In striking contrast, we had shown before (4) that in knock-in single-transgenic TH mice ϳ30% of their B cells bind MOG ( Fig. 1) , although the B cell repertoire is diverse. The transgenic Ig H-chain combines with some, but not all, endogenous L-chains to reconstitute MOG specificity. The MOG-binding pattern of specific B cells is heterogeneous, ranging from very low to high density by identical surface IgM (Fig. 1 ), but MOG-reactive B cells are not demonstrably tolerized and seem to undergo normal development (4) .
Unexpectedly, B cells isolated from spleen or bone marrow of double-transgenic TH mog mice showed a frequency of MOGbinding cells indistinguishable from that of single-transgenic TH mice ( Fig. 1) . Furthermore, the titer of MOG-specific Ab in the serum of TH mog mice was not higher than in TH mice. The absence of an increased frequency of MOG-reactive B cells cannot be explained by clonal deletion (12, 13, 24) , because the total number of (B220 ϩ IgM ϩ ) B cells in the spleen and bone marrow of TH mog mice was not reduced, as compared with TH mice or wild-type controls ( Fig. 1 ). We also exclude anergy, given that the concentrations of surface IgM as compared with surface IgD are normal in these mice (Fig. 1, top) .
Expression 
Transgenic Ig mog expression in immature B cells
To track the regulation of the mog transgene at early stages of differentiation, we analyzed immature B cells in immune organs from neonatal mice. Like other Ig-transgenic mice, our transgenics showed a global acceleration of B cell development, best explained by the presence of preformed Ig (H or L) genes. The ratio of B220 ϩ IgM ϩ to immature B220 ϩ IgM Ϫ pre-B cells was 2-fold higher in the neonatal liver of single-transgenic TH mice than in wild-type littermates (1 vs 0.66, Table I ), and this ratio was further elevated in double-transgenic TH mog neonates (2 vs 1, Table I ). More specifically, the proportion of MOG-binding IgM ϩ B cells in the liver of double-transgenic TH mog neonates is higher than in single-transgenic TH littermates (Table II and Fig. 2 ). In fact, double staining with IgM a allotype-specific Ab (which detect the TH chain) and biotinylated MOG reveals a tight correlation between IgM surface density and MOG binding intensity in TH mog neonates (Fig. 2, top) . This particular staining pattern, which was found in TH mog , but much less in TH pups, indicates a B cell population expressing both transgenic Ig H-and L-chains exclusively.
The proportion of MOG-binding B cells within this IgM ϩ MOG ϩ population is higher in the liver than in the spleen of neonatal TH mog mice (Fig. 2 , top, and Table II) . This distinctive B cell phenotype prevailed in perinatal TH mog mice, whereas it decreased in the spleen within the first 6 days after birth. By then, the MOG-binding pattern of splenic B cells is indistinguishable in TH mog and TH mice and comparable to the phenotype of B cells in adult transgenic mice (Table II) .
To identify the transgenic L-chains during perinatal development, we separated neonatal liver cells into MOG-binding and -nonbinding B cell fractions and analyzed their L gene transcripts by RT-PCR. As shown in Table III and TH mice for expression of RAG genes (Fig. 3) . As in normal B cell differentiation, where the appearance of surface IgM coincides with a shutdown of the rearrangement machinery, we detected neither RAG-1 nor RAG-2 in the IgM ϩ MOG-binding cells from single-transgenic TH neonatal liver (Fig. 3) . In contrast, both RAG-1 and RAG-2 transcripts were detected in the MOG-binding cell fraction from neonatal double-transgenic TH mog liver (Fig.  3) . Transcription of RAG-1 and RAG-2 was also detected in the excluded fractions from both TH mog and TH mice, given that this fraction includes surface Ig-negative pre-B cells, actively rearranging endogenous L-chains. Persistent or reactivated Ig rearrangement in IgM-positive B cells of neonatal TH mog mice explains the observed expression of endogenous L genes. Receptor editing in such early TH mog -transgenic B cells leads to silencing of the transgenic mog gene and expression of endogenous L genes. However, like in single-transgenic TH mice, this process does not abrogate MOG specificity totally, because about one-third of endogenous L-chains generate MOG binding on pairing with the TH chain ( Fig. 1 and Table II) .
Transgenic TH mog B cells on a RAG-2-deficient background
What would be the destiny of self-reactive transgenic B cells without rescue by receptor editing? We crossed the RAG-2 knockout mutation into the TH mog -transgenic mice and followed the appearance of B lymphocytes in these animals. As expected, IgM ϩ B cells are completely absent both in the adult parental RAG-2 Ϫ/Ϫ (28) and in TH/RAG-2 Ϫ/Ϫ mice (Fig. 4) . In contrast, in TH mog / RAG-2 Ϫ/Ϫ mice, a small but significant population (bone marrow) of B220 ϩ IgM ϩ B cells is reproducibly observed in both bone marrow and spleen (Fig. 4, marked (Fig. 4 , lower panels), these cells are qualified as immature B cells. This conclusion is supported by their binding of the recently described mAb 493, a further marker of immature B lymphocytes (20) (Fig. 5) , excluding the possibility that these cells represent a special form of mature, functionally inactivated, anergic B cells (29) . As shown in Fig. 5 
MOG gene expression does not affect differentiation of MOGspecific transgenic B cells
The present results suggest that the transgenic, MOG specific B cells are affected by self-tolerizing processes that result in receptor editing. However, they do not reveal the nature of the censoring self-determinant involved in tolerization. To explore the possible participation of the MOG gene products, we crossed TH and TH mog mice into a MOG knockout mutant, i.e., completely devoid of MOG protein (Fig. 6A) . In the absence of MOG, the phenotype of MOG binding B cells in TH and TH mog mice is identical with that observed in MOG-sufficient animals (Fig. 6B, top) . This experiment also excludes a possible editing of the TH gene, as the number of Id-positive B cells in the MOG Ϫ/Ϫ backcross is comparable with that found in MOG-expressing mice (Fig. 6B,  bottom) . Thus, MOG per se cannot be responsible for the tolerization of the transgenic specificity in TH mog mice.
Discussion
We have conducted experiments designed to explore whether (and which) mechanisms of self-tolerance could affect the development of B lymphocytes specific for a brain myelin autoantigen, MOG. The paradigm used was a transgenic gene replacement mouse carrying in its genome the rearranged Ig genes of the MOG-reactive hybridoma 8.18C5. Previous work had demonstrated that in singletransgenic mice the 8.18C5-derived Ig H-chain is expressed along with endogenous L-chains without any apparent impairment and that this IgH chain alone confers MOG specificity in about onethird of the B cells (4) . We now report that, in striking contrast, in double-transgenic mice carrying both the Ig H and L genes of 8.18C5 (TH mog ), the expression of the transgenic mog gene is not permitted but is replaced by endogenous L-chains.
Ig receptor editing on contact with self-determinants is one of the cardinal mechanisms to generate and maintain immunological self-tolerance on the B cell level. To date, it has been mainly been studied in immature B cells arising in the bone marrow of adult mice, leaving neonatal B cell tolerance less well characterized (30) . In our system, in neonatal liver and spleen of double-transgenic TH mog mice, a high proportion of B cells expressed the transgenic B cell receptor, as indicated by the IgM/MOG double staining pattern characteristic of monospecific B lymphocytes. As may be expected, the MOG-binding B cells almost exclusively expressed mog gene transcripts, showing that at this developmental stage the cells are not yet completely tolerized. However, the expression of RAG-1 and RAG-2 genes in this cell subset points to an ongoing process of receptor editing. In contrast, neonatal B cells, which did not bind MOG, predominantly expressed endogenous L-chains, indicating replacement of the transgenic mog chain as a result of editing.
The molecular nature of the mechanism(s) responsible for obliteration of the transgenic mog chain in TH mog mice remains speculative. In an anti-DNA Ig transgenic model, Gay et al. (16) proposed that editing would occur at the level of Ig H-and L-chain pairing. Our system seems to rely primarily on transcriptional down-regulation, as indicated by the predominance of endogenous Ig transcripts over transgenic mog transcripts in edited TH mogtransgenic B cells. Editing of the Ig receptor in TH mog mice affects only the mog L-chain, although replacement inactivation of the knocked-in TH gene would also alter the transgenic specificity, and can be demonstrated upon immunization of TH mice (31) . Yet the Id encoded by the TH transgene is maintained in double-transgenic TH mog B cells in a proportion similar to that in singletransgenic TH B cells (Fig. 6 and Ref. 4) . This type of secondary rearrangement has been described also in other IgH knock-in mice (32) (33) (34) (35) . In fact, some of these transgenic models suggest that the L-chain locus is the preferential target for receptor editing (25, 26) .
The lack of an enhanced MOG-binding fraction of B cells in TH mog double-transgenic mice, as compared with TH singletransgenic animals, could alternatively be interpreted to indicate imperfect fit of the transgenic mog L-chain with the knock-in TH chain. This could result in insufficient allelic exclusion of endogenous L-chains and/or lack of positive selection of the transgenic Ig pair. Our experimental observations, however, clearly contradict this interpretation. First, in the MOG ϩ fraction of fetal liver and in the RAG-deficient background, the transgenic mog is able to form disulfide bonds with the TH chain and be efficiently anchored onto the surface of IgM ϩ B cells (Figs. 2 and 4) . The concentrations of surface IgM on these cells is comparable with that of normal cells at the same developmental stage (Figs. 2 and 4) . Second, we show that early B cells in fetal liver of double-transgenic mice include a large fraction (the MOG-binding one) in which the transgenic mog chain is expressed almost exclusively. As shown in Table III Why are MOG-binding B cells that simultaneously express both transgenic specific Ig H-and L-chains censored while at the same time MOG-binding B cells using the same Ig H-chain but different L-chains develop normally? It appears that an unknown self-structure present in the B cell compartments controls initiation of editing. MOG is not expressed outside the CNS (9). Although we assume that in wild-type as well as in double transgenic TH mog mice, the formation of the MOG-specific repertoire occurs in the absence of the nominal Ag, this is definitely the case in MOG knockout mice (Fig. 6 ). There is no difference in MOG-specific B cell development between MOG-expressing and MOG-deficient mice. Indeed, all our data indicate that the MOG-specific B cell receptor in TH mog double-transgenic B cells is confronted with a self-Ag distinct of MOG and that this encounter is responsible for the induction of tolerance. The nature of the self-Ag(s) cross-reacting with MOG is unknown. Preliminary attempts to detect putative autoantigens in tissue preparations using the 8.18C5 Ab failed. However, it is known that B cell receptor editing can be induced by very low affinity interactions that may be difficult to measure (37, 38) . We are currently testing butyrophilins, a large protein family that, apart from MOG, contains numerous milk proteins and costimulatory molecules of the B7 series (39 -41) .
Considering the highly efficient tolerization of double-transgenic TH mog B lymphocytes in vivo, the derivation of the original hybridoma 8.18C5 appears enigmatic. At least in theory, the hybridoma precursor B cell should have been edited in the donor mouse, just as the double-transgenic B cells in our experiments are edited. Alternatively, the original B cell may have acquired its MOG/self specificity at a mature stage, after immunization. However, as stated before, the V region of the mog transgene represents an unmutated V-8 gene, identical with a V gene previously found in a phosphorylcholine-specific hybridoma (19) . In addition, the only bona fide somatic mutation found in the V region of the TH gene corresponds to a silent point mutation (ACT-Thr3 ACGThr) within the rearranged DSP2.7 element (4). Therefore, extensive somatic mutation seems not to explain the heteroclitic specificity associated with the nominal MOG specificity of 8.18C5.
Alternatively, the autoreactive B cell clone could have been derived from the B-1 subset of lymphocytes, a population of mainly peritoneal B cells enriched for self-reactivity. Our finding that TH (and TH mog ) mice are depleted of peritoneal B-1 cells and that the few B-1 cells left in these mice express preferentially endogenous Ig's may argue against this possibility (Ref. 4 and data not shown). Finally, some B cells expressing autoreactive IgG but not IgM are viable and provoke autoimmunity in transgenic mice (42, 43) . There is the possibility that under the conditions of repeated immunization, rare, autoreactive, MOG-specific B cell clones, like 8.18C5, sneaking through tolerogenesis in bone marrow were recruited to undergo isotype switch and escape tolerance.
Our data show that the developing immune system is able to distinguish between self-specificity defined by the TH chain alone (MOG), which is not recognized and censored outside the CNS, and a second self-specificity given by the combination of the TH chain with this particular mog L-chain. We propose that through this second specificity TH mog B cells bind to an autoantigen cross-reactive with MOG and become efficiently tolerized via editing of their transgenic L-chain without eliminating the MOG binding potential. This particular form of chain-specific split tolerance within B cells results in divergent tolerance and persistence of an organ-specific, potentially pathogenic autoreactive clone.
